Screener
Climb Bio, Inc. CLYM Shares (Diluted)
Shares (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Climb Bio, Inc. in its filing.
Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.
The source filing: Climb Bio, Inc.’s 10-Q, filed May 7, 2026.
- Filed
- May 7, 2026, 7:30 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-210357
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Total other income, net | 1,489 | 2,237 |
| Net loss | $(13,722) | $(20,781) |
| Net loss per share, basic and diluted | $(0.20) | $(0.31) |
| Weighted-average common shares outstanding, basic and diluted | 68,207,313 | 67,462,450 |
| Comprehensive loss: | ||
| Net loss | $(13,722) | $(20,781) |
| Other comprehensive income: | ||
| Unrealized gain (loss) on marketable securities | (278) | 263 |
Item 1. Condensed Consolidated Financial Statements (unaudited)
FAQ
- What is Climb Bio, Inc.'s shares (diluted)?
- Climb Bio, Inc. (CLYM) reported shares (diluted) of 68.2M in Q1 2026.
- How has Climb Bio, Inc.'s shares (diluted) changed year-over-year?
- Climb Bio, Inc.'s shares (diluted) increased by 1.1% year-over-year, from 67.5M to 68.2M.
- What is the long-term trend for Climb Bio, Inc.'s shares (diluted)?
- Over 4 years (2021 to 2025), Climb Bio, Inc.'s shares (diluted) has grown at a 67.0% compound annual growth rate (CAGR), from 34.8M to 270.9M.
- What does shares (diluted) mean?
- The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.
Ask your AI about Climb Bio, Inc.'s shares (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude